Zentalis Pharmaceuticals, Inc. (ZNTL)
1.36
-0.13
(-8.72%)
USD |
NASDAQ |
Nov 18, 16:00
1.42
+0.06
(+4.41%)
Pre-Market: 08:39
Zentalis Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | 98.82% |
| September 30, 2024 |
| Date | Value |
|---|---|
| June 30, 2024 | |
| March 31, 2024 | 99.20% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| ARS Pharmaceuticals, Inc. | 73.22% |
| ACADIA Pharmaceuticals, Inc. | 89.75% |
| Alnylam Pharmaceuticals, Inc. | 75.19% |
| Anika Therapeutics, Inc. | 61.57% |
| Savara, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -70.81% |
| Return on Assets | -52.28% |
| Return on Invested Capital | -59.36% |
| Return on Net Operating Assets | -452.2% |